The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy

被引:2
作者
Waaijer, M. E. C. [1 ]
Lemij, A. A. [2 ,3 ]
de Boer, A. Z. [2 ,3 ]
Bastiaannet, E. [2 ,3 ]
van den Bos, F. [1 ]
Derks, M. G. M. [3 ]
Kroep, J. R. [3 ]
Liefers, G. J. [2 ]
Portielje, J. E. A. [3 ]
de Glas, N. A. [3 ]
机构
[1] Leiden Univ, Dept Gerontol & Geriatr, Med Ctr, Leiden, Netherlands
[2] Leiden Univ, Dept Surg, Med Ctr, Leiden, Netherlands
[3] Leiden Univ, Dept Med Oncol, Med Ctr, Post Zone C7-Q,POB 9600 RC, Leiden, Netherlands
关键词
Breast cancer; Geriatric oncology; Primary endocrine therapy; SURVIVAL; OMISSION; SURGERY;
D O I
10.1007/s10549-023-07029-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IntroductionIn recent years, primary surgical treatment of older women with non-metastatic breast cancer has decreased in favor of primary endocrine therapy (PET). PET can be considered in women with a remaining life expectancy of less than five years. The aim of this study was to (1) assess the risk of distant metastases and other cause mortality over ten years in women aged 65 and older with stage I-III breast cancer treated with PET, (2) whether this was associated with geriatric characteristics and comorbidities and to (3) describe the reasons on which the choice for PET was made.MethodsWomen were included from the retrospective FOCUS cohort, which comprises all incident women diagnosed with breast cancer aged 65 or older between January 1997 and December 2004 in the Comprehensive Cancer Center Region West in the Netherlands. We selected women (N = 257) with stage I-III breast cancer and treated with PET from this cohort. Patient characteristics (including comorbidity, polypharmacy, walking, cognitive and sensory impairment), treatment and tumor characteristics were retrospectively extracted from charts. Outcomes were distant metastasis and other cause mortality. Cumulative incidences were calculated using the Cumulative Incidence for Competing Risks method (CICR); and subdistribution hazard ratios (SHR) were tested between groups based on age, geriatric characteristics and comorbidity with the Fine and Gray model.ResultsWomen treated with PET were on average 84 years old and 41% had one or more geriatric characteristics. Other cause mortality exceeded the cumulative incidence of distant metastasis over ten years (83 versus 5.6%). The risk of dying from another cause further increased in women with geriatric characteristics (SHR 2.06, p < 0.001) or two or more comorbidities (SHR 1.72, p < 0.001). Often the reason for omitting surgery was not recorded (52.9%), but if recorded surgery was omitted mainly at the patient's request (18.7%).DiscussionThis study shows that the cumulative incidence of distant metastasis is much lower than other cause mortality in older women with breast cancer treated with PET, especially in the presence of geriatric characteristics or comorbidities. This confirms the importance of assessment of geriatric characteristics to aid counseling of older women.
引用
收藏
页码:471 / 478
页数:8
相关论文
共 25 条
  • [1] Biganzoli L, 2021, LANCET ONCOL, P327
  • [2] Effect of omission of surgery on survival in patients aged 80 years and older with early-stage hormone receptor-positive breast cancer
    de Boer, A. Z.
    de Glas, N. A.
    Marang-van De Mheen, P. J.
    Dekkers, O. M.
    Siesling, S.
    de Munck, L.
    de Ligt, K. M.
    Liefers, G. J.
    Portielje, J. E. A.
    Bastiaannet, E.
    [J]. BRITISH JOURNAL OF SURGERY, 2020, 107 (09) : 1145 - 1153
  • [3] Impact of omission of surgery on survival of older patients with breast cancer
    de Glas, N. A.
    Jonker, J. M.
    Bastiaannet, E.
    de Craen, A. J. M.
    van de Velde, C. J. H.
    Siesling, S.
    Liefers, G. -J.
    Portielje, J. E. A.
    Hamaker, M. E.
    [J]. BRITISH JOURNAL OF SURGERY, 2014, 101 (11) : 1397 - 1404
  • [4] Postoperative complications and survival of elderly breast cancer patients: a FOCUS study analysis
    de Glas, N. A.
    Kiderlen, M.
    Bastiaannet, E.
    de Craen, A. J. M.
    van de Water, W.
    van de Velde, C. J. H.
    Liefers, G. J.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2013, 138 (02) : 561 - 569
  • [5] Comprehensive geriatric assessment and comorbidities predict survival in geriatric oncology
    Denewet, Nathalie
    De Breucker, Sandra
    Luce, Sylvie
    Kennes, Bernard
    Higuet, Sandra
    Pepersack, Thierry
    [J]. ACTA CLINICA BELGICA, 2016, 71 (04) : 206 - 213
  • [6] Cancer statistics for African Americans, 2019
    DeSantis, Carol E.
    Miller, Kimberly D.
    Sauer, Ann Goding
    Jemal, Ahmedin
    Siegel, Rebecca L.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2019, 69 (03) : 211 - 233
  • [7] Comprehensive geriatric assessment for older patients with cancer
    Extermann, Martine
    Hurria, Arti
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (14) : 1824 - 1831
  • [8] How we use noncancer-specific survival prediction in geriatric oncology: A Young International Society of Geriatric Oncology and Nursing & Allied Health Interest Group initiative
    Gomez-Moreno, Carolina
    Pilleron, Sophie
    Neuendorff, Nina Rosa
    Soto-Perez-de-Celis, Enrique
    [J]. JOURNAL OF GERIATRIC ONCOLOGY, 2022, 13 (04) : 516 - 520
  • [9] Omission of surgery in elderly patients with early stage breast cancer
    Hamaker, Marije E.
    Bastiaannet, Esther
    Evers, Dorothea
    van de Water, Willemien
    Smorenburg, Carolien H.
    Maartense, Ed
    Zeilemaker, Anneke M.
    Liefers, Gerrit-Jan
    van der Geest, Lydia
    de Rooij, Sophia E.
    van Munster, Barbara C.
    Portielje, Johanneke E. A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 (03) : 545 - 552
  • [10] The Value of Geriatric Assessments in Predicting Treatment Tolerance and All-Cause Mortality in Older Patients With Cancer
    Hamaker, Marije E.
    Vos, Alinda G.
    Smorenburg, Carolien H.
    de Rooij, Sophia E.
    van Munster, Barbara C.
    [J]. ONCOLOGIST, 2012, 17 (11) : 1439 - 1449